Show Summary Details
Page of

Multiple cardiovascular risk intervention 

Multiple cardiovascular risk intervention
Chapter:
Multiple cardiovascular risk intervention
Author(s):

Miles Fisher

DOI:
10.1093/med/9780199596171.003.0059
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 April 2019

Cardiovascular disease is a common cause of morbidity and mortality in people with type 2 diabetes. Some guidelines define diabetes as a coronary heart disease equivalent, requiring multiple cardiovascular risk factor reduction

The treatment of hyperglycaemia in type 2 diabetes reduces cardiovascular events, and on long-term follow up reduces cardiovascular and total mortality. Metformin and pioglitazone have advantages in subgroups of patients...

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.